AA

Andrew Adams

Co-Founder & Managing Partner at Oak HC/FT

United States

Invests in

Locations:

  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Work Experience

2014

  • Co-Founder & Managing Partner

    2014

    Active Investments: August Bioservices, Curana, DispatchHealth, Galileo, Infusion for Health, Marathon Health, Medical Home Network, Noom, Precision Medicine Group, Remodel Health, Reveleer, Rialtic, Trovo Health, Unified Women's Healthcare, US HealthVest, Veda Data Prior Investments: American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (NASDAQ: CLRT; acquired by GE Healthcare), Core Informatics (acquired by Thermo Fisher Scientific), GeneDx Holdings (NASDAQ: WGS), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), Independent Living Systems, LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy), Limeade (ASX: LME), Maestro Health (acquired by AXA Group), NetSpend Corporation (NASDAQ: NTSP; acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by Clayton Dubilier & Rice)

  • General Partner

    2003 - 2014